
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.
The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 193 pages)
Export 15 results:
Author Title Type [ Year
Filters: First Letter Of Title is C and Author is Suissa, S. [Clear All Filters]
“Comparative cardiovascular and hypoglycemic safety of glimepiride in type 2 diabetes: A population-based cohort study”, Diabetes Obes Metab, 2019.
, , , “Comparative effect of statins on the risk of incident Alzheimer disease”, Neurology, vol. 90, pp. e179-e187, 2018.
, “Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study”, Lancet Respir Med, vol. 6, pp. 855-862, 2018.
, , “Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events”, Eur Respir J, vol. 49, 2017.
, “Cardiac glycosides use and the risk of lung cancer: a nested case-control study”, BMC Cancer, vol. 14, p. 573, 2014.
, “Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study”, Menopause, vol. 21, pp. 1023-6, 2014.
, “The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation”, Thromb Haemost, vol. 109, pp. 431-9, 2013.
, , “Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence”, Breast Cancer Res Treat, vol. 126, pp. 695-703, 2011.
, “Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study”, Pharmacoepidemiol Drug Saf, vol. 19, pp. 335-42, 2010.
, “Combined oral contraceptive use and the risk of systemic lupus erythematosus”, Arthritis Rheum, vol. 61, pp. 476-81, 2009.
, “Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study”, Stroke, vol. 37, pp. 1725-30, 2006.
,